Skip to content

A study on the application of exercise interventions based on the International Classification of Functioning, Disability and Health in patients with Inflammatory Bowel Disease

A study on the application of exercise interventions based on the International Classification of Functioning, Disability and Health in patients with Inflammatory Bowel Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120778
Enrollment
Unknown
Registered
2026-03-19
Start date
2026-03-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

Control group:Routine nursing measures
Intervention group:Received an ICF-based exercise intervention in addition to the control group’s treatment

Sponsors

The Affiliated Wuxi People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female aged between 18 and 65 years (included); 2. Patients diagnosed with IBD according to the diagnostic criteria established in 2018 by the Inflammatory Bowel Disease Collaborative Group of the Chinese Society of Gastroenterology; 3. Disease duration of >=1 year; 4. Assessed by a specialist as fit to safely participate in the exercise intervention (intervention group) or study-related assessments (control group); 5. Willing to participate in this trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Language barriers preventing participation in intervention guidance or health education; 2. Severe disease activity requiring urgent adjustment of medication or surgical treatment; 3. Pregnancy, plans to become pregnant, or pregnancy occurring during the intervention period; 4. Known cardiac disease or severe musculoskeletal injury, rendering safe participation in exercise or completion of study assessments impossible; 5. Co-existing neurological or psychiatric conditions; 6. Other circumstances preventing completion of the 12-week study period and follow-up.

Design outcomes

Primary

MeasureTime frame
Quality of life in patients with inflammatory bowel disease;

Secondary

MeasureTime frame
Physical Endurance;Fatigue;Health-related quality of life;Disease activity;

Countries

China

Contacts

Public ContactJiang Xin

The Affiliated Wuxi People's Hospital of Nanjing Medical University

jinghe10342@163.com+86 138 6171 9957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026